Article
Omicron sub-lineage BA.2 may have “substantial growth advantage,” UKHSA reports
31 Jan 2022
Abstract excerpt
Omicron sub-lineage BA.2 may have "substantial growth advantage," UKHSA reports
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
